Cargando…

Identification of Lysosome‐Associated Protein Transmembrane‐4 as a Novel Therapeutic Target for Osteosarcoma Treatment

OBJECTIVE: The aim of the study is to evaluate the expression of lysosome‐associated protein transmembrane‐4 (LAPTM4B) in human osteosarcoma tissue samples collected in our hospital, and to explore the possible correlations between the clinical pathological features of osteosarcoma patients and LAPT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhe‐xiang, Guo, Meng‐yang, Ren, Jing, Li, Gui‐shi, Sun, Xu‐guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Scientific Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454209/ https://www.ncbi.nlm.nih.gov/pubmed/32558212 http://dx.doi.org/10.1111/os.12692

Ejemplares similares

Identification of Abnormal Spindle Microtubule Assembly as a Promising Therapeutic Target for Osteosarcoma
por: Lin, Peng, et al.
Publicado: (2020)

Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma
por: Wang, Zhe-Xiang, et al.
Publicado: (2020)

Lysosomal-associated protein transmembrane-4 beta: a novel potential biomarker for cancer therapy with multiple functions
por: Xu, Xi-Chao, et al.
Publicado: (2021)

Lysosome-associated protein transmembrane4β is involved in multidrug resistance processes of colorectal cancer
por: Huang, Yue-Nan, et al.
Publicado: (2017)

Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma
por: Gong, Yubao, et al.
Publicado: (2021)

Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation
por: Jiang, Bo, et al.
Publicado: (2022)

Lysosomal-Associated Protein Transmembrane 5 Functions as a Novel Negative Regulator of Pathological Cardiac Hypertrophy
por: Gao, Lu, et al.
Publicado: (2021)

Lysosomal-Associated Protein Transmembrane 4 Beta-35 Overexpression Is a Novel Independent Prognostic Marker for Gastric Carcinoma
por: Liu, Luying, et al.
Publicado: (2015)

Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy
por: Niu, Jianfang, et al.
Publicado: (2020)

The Roles of KIFC1 in the Development of Osteosarcoma: Characterization of Potential Therapeutic Targets
por: Liang, Li-Yan, et al.
Publicado: (2022)

Lysosomal-associated transmembrane protein 5 deficiency exacerbates cerebral ischemia/reperfusion injury
por: Zhang, Zongyong, et al.
Publicado: (2022)

Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma
por: Han, Qi-cai, et al.
Publicado: (2021)

Lysosomes as a therapeutic target
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2019)

Frequently expressed glypican‐3 as a promising novel therapeutic target for osteosarcomas
por: Nie, Jun‐Hua, et al.
Publicado: (2022)

Identification of Novel Target for Osteosarcoma by Network Analysis
por: Zhi, Li-Qiang, et al.
Publicado: (2018)

Lysosomal quality control of cell fate: a novel therapeutic target for human diseases
por: Zhu, Sheng-yu, et al.
Publicado: (2020)

In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer
por: Tao, Deyou, et al.
Publicado: (2019)

Roles of microRNA‐22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin‐mediated Autophagy
por: Wang, Peng, et al.
Publicado: (2019)

Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma
por: Fan, Gentao, et al.
Publicado: (2023)

Upregulation and biological function of transmembrane protein 119 in osteosarcoma
por: Jiang, Zhen-Huan, et al.
Publicado: (2017)

The Charcot-Marie-Tooth diseases: how can we identify and develop novel therapeutic targets?
por: Roberts, Rhys C.
Publicado: (2012)

Role of the N-terminal transmembrane domain in the endo-lysosomal targeting and function of the human ABCB6 protein
por: Kiss, Katalin, et al.
Publicado: (2015)

The lysosome as a novel therapeutic target of EGFR-mediated tumor inflammation
por: Sung, Woo Jung, et al.
Publicado: (2022)

Key Prognostic Value of Lysosomal Protein Transmembrane 5 in Kidney Renal Clear Cell Carcinoma
por: Li, Bin, et al.
Publicado: (2022)

Osteosarcoma mechanobiology and therapeutic targets
por: Shoaib, Zunaira, et al.
Publicado: (2021)

Availability and Readability of Online Patient Information on Osteosarcoma: Assessment of Pediatric Hospital and National Cancer Institute-Designated Cancer Center (NCIDCC) Osteosarcoma Web Pages
por: Young, Jason, et al.
Publicado: (2020)

Silencing Transmembrane Protein 45B (TNEM45B) Inhibits Proliferation, Invasion, and Tumorigenesis in Osteosarcoma Cells
por: Li, Yan, et al.
Publicado: (2017)

Transmembrane Protein 175, a Lysosomal Ion Channel Related to Parkinson’s Disease
por: Tang, Tuoxian, et al.
Publicado: (2023)

Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy
por: Ito, Yoko, et al.
Publicado: (2018)

A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency
por: Tordo, Julie, et al.
Publicado: (2018)

Identification of co-expression modules and pathways correlated with osteosarcoma and its metastasis
por: Wang, Jian-sheng, et al.
Publicado: (2019)

Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target
por: Nie, Jun-Hua, et al.
Publicado: (2021)

Lysosomes in acute myeloid leukemia: potential therapeutic targets?
por: Rafiq, Sreoshee, et al.
Publicado: (2021)

ADCK1 is a potential therapeutic target of osteosarcoma
por: Zhuo, Bao-biao, et al.
Publicado: (2022)

Identification of therapeutic targets for osteosarcoma by integrating single-cell RNA sequencing and network pharmacology
por: Wang, Yan, et al.
Publicado: (2023)

A transmembrane protein family gene signature for overall survival prediction in osteosarcoma
por: Du, Yuehui, et al.
Publicado: (2022)

TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer
por: Kim, Semi
Publicado: (2023)

Identification of a factor controlling lysosomal homeostasis using a novel lysosomal trafficking probe
por: Ishii, Shunsuke, et al.
Publicado: (2019)

Induction of Lysosome‐associated Protein Transmembrane 4 Beta via Sulfatase 2 Enhances Autophagic Flux in Liver Cancer Cells
por: Ha, Yeonjung, et al.
Publicado: (2019)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iarp77j3atg7gmj28v060mbu7m